Roivant Sciences (ROIV) Stock Surges After 2025 Investor Day: Pipeline Milestones, Cash Runway and Analyst Forecasts
December 11, 2025 – Roivant Sciences Ltd. (Nasdaq: ROIV) has just given Wall Street a dense dose of biotech optimism. Here’s what today’s Investor Day and the latest data mean for the stock. ROIV stock today: rally near 52‑week highs Roivant shares traded around the low‑$20s on December 11, with intraday prices near $21.5 according to real‑time market data. That move builds on a powerful run: The immediate catalyst for today’s jump: Roivant’s 2025 Investor Day, where management laid out an aggressive roadmap of 3+ potential product launches, 4+ expected NDA/BLA filings, and 8+ pivotal readouts over the next three